MK
Matthew Keller HC Wainwright & Co Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
12
Avg Return
Past Year
Past Year
8.6%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
91.7%
Neutral
8.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Reiterated
| $6 |
450%
upside
| 2 | -15% |
0
%
| 30 Dec ‘25 9 days ago |
|
|
|
Buy
Maintained
| $11 |
244%
upside
| 2 | +10% |
0
%
| 17 Dec ‘25 22 days ago |
|
|
|
Buy
Assumed
| $6 |
1,071%
upside
| 1 | -56% |
0
%
| 14 Nov ‘25 1 month ago |
|
|
|
Neutral
Downgraded
| – | – | 1 | – |
–
| 30 Oct ‘25 2 months ago |
|
|
|
Buy
Reiterated
| $31 |
962%
upside
| 2 | -18% |
0
%
| 30 Sep ‘25 3 months ago |
|
|
|
Buy
Reiterated
| $43 | – | 2 | +68% |
0
%
| 24 Sep ‘25 3 months ago |
|
|
|
Buy
Initiated
| $18 |
138%
upside
| 1 | -7.7% |
0
%
| 26 Aug ‘25 4 months ago |
|
|
|
Buy
Reiterated
| $14 |
1,076%
upside
| 1 | -46% |
0
%
| 15 Aug ‘25 4 months ago |
|